20 January 2019

GMP rules to fuel M&As in pharmaceutical sector, paper says

A total of 796 drug manufacturers, or 60.3 percent of the country’s 1,319 producers, have met the requirements under the new Good Manufacturing Practice (GMP) guidelines, the Securities Times reported Thursday, citing data from the China Food and Drug Administration as of Dec. 31, 2013. As many as 523 manufacturers have been forced to halt production after failing to obtain the necessary qualifications, presenting good opportunities for mergers and acquisitions within the industry, an unnamed analyst was quoted as saying.

– Contact HKEJ at [email protected]




    EJI Weekly Newsletter

    Please click here to unsubscribe